ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneNames,Count
R-HSA-1474244,Extracellular matrix organization,18/33,271/9133,1.3e-19,1.7e-17,1.2e-17,COL5A2/ADAM12/COL5A1/FN1/P4HA3/ASPN/COL10A1/COMP/COL1A1/ACAN/COL3A1/COL1A2/LOX/PCOLCE/COL11A1/COL4A4/COL2A1/ITGA8,18
R-HSA-3000178,ECM proteoglycans,12/33,69/9133,4e-18,2.6e-16,1.9e-16,COL5A2/COL5A1/FN1/ASPN/COMP/COL1A1/ACAN/COL3A1/COL1A2/COL4A4/COL2A1/ITGA8,12
R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,11/33,59/9133,5.3e-17,2.2e-15,1.6e-15,COL5A2/COL5A1/COL10A1/COL1A1/COL3A1/COL1A2/LOX/PCOLCE/COL11A1/COL4A4/COL2A1,11
R-HSA-1474290,Collagen formation,12/33,86/9133,6.6e-17,2.2e-15,1.6e-15,COL5A2/COL5A1/P4HA3/COL10A1/COL1A1/COL3A1/COL1A2/LOX/PCOLCE/COL11A1/COL4A4/COL2A1,12
R-HSA-1650814,Collagen biosynthesis and modifying enzymes,11/33,64/9133,1.4e-16,3.7e-15,2.6e-15,COL5A2/COL5A1/P4HA3/COL10A1/COL1A1/COL3A1/COL1A2/PCOLCE/COL11A1/COL4A4/COL2A1,11
R-HSA-216083,Integrin cell surface interactions,11/33,79/9133,1.6e-15,3.6e-14,2.6e-14,COL5A2/COL5A1/FN1/COL10A1/COMP/COL1A1/COL3A1/COL1A2/COL4A4/COL2A1/ITGA8,11
R-HSA-3000171,Non-integrin membrane-ECM interactions,10/33,57/9133,3.2e-15,6.1e-14,4.3e-14,COL5A2/COL5A1/FN1/COL10A1/COL1A1/COL3A1/COL1A2/COL11A1/COL4A4/COL2A1,10
R-HSA-8948216,Collagen chain trimerization,9/33,41/9133,1e-14,1.7e-13,1.2e-13,COL5A2/COL5A1/COL10A1/COL1A1/COL3A1/COL1A2/COL11A1/COL4A4/COL2A1,9
R-HSA-8874081,MET activates PTK2 signaling,8/33,30/9133,6.4e-14,9.4e-13,6.7e-13,COL5A2/COL5A1/FN1/COL1A1/COL3A1/COL1A2/COL11A1/COL2A1,8
R-HSA-1474228,Degradation of the extracellular matrix,11/33,124/9133,2.8e-13,3.6e-12,2.6e-12,COL5A2/COL5A1/FN1/COL10A1/COL1A1/ACAN/COL3A1/COL1A2/COL11A1/COL4A4/COL2A1,11
R-HSA-1442490,Collagen degradation,9/33,58/9133,3e-13,3.6e-12,2.6e-12,COL5A2/COL5A1/COL10A1/COL1A1/COL3A1/COL1A2/COL11A1/COL4A4/COL2A1,9
R-HSA-8875878,MET promotes cell motility,8/33,41/9133,1e-12,1.1e-11,8e-12,COL5A2/COL5A1/FN1/COL1A1/COL3A1/COL1A2/COL11A1/COL2A1,8
R-HSA-6806834,Signaling by MET,8/33,76/9133,1.9e-10,1.9e-9,1.3e-9,COL5A2/COL5A1/FN1/COL1A1/COL3A1/COL1A2/COL11A1/COL2A1,8
R-HSA-3000170,Syndecan interactions,6/33,26/9133,3e-10,2.8e-9,2e-9,COL5A2/COL5A1/FN1/COL1A1/COL3A1/COL1A2,6
R-HSA-2243919,Crosslinking of collagen fibrils,5/33,18/9133,3.7e-9,3.3e-8,2.3e-8,COL1A1/COL1A2/LOX/PCOLCE/COL4A4,5
R-HSA-419037,NCAM1 interactions,5/33,36/9133,1.6e-7,1.3e-6,9.1e-7,COL5A2/COL5A1/COL3A1/COL4A4/COL2A1,5
R-HSA-186797,Signaling by PDGF,5/33,56/9133,1.5e-6,1.2e-5,8.3e-6,COL5A2/COL5A1/COL3A1/COL4A4/COL2A1,5
R-HSA-375165,NCAM signaling for neurite out-growth,5/33,57/9133,1.6e-6,1.2e-5,8.6e-6,COL5A2/COL5A1/COL3A1/COL4A4/COL2A1,5
R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,10/33,491/9133,5.6e-6,3.9e-5,2.7e-5,COL5A2/ADAM12/COL5A1/FN1/COL1A1/COL3A1/COL1A2/COL11A1/COL4A4/COL2A1,10
R-HSA-2214320,Anchoring fibril formation,3/33,15/9133,1.9e-5,1.3e-4,8.9e-5,COL1A1/COL1A2/COL4A4,3
R-HSA-3000480,Scavenging by Class A Receptors,3/33,16/9133,2.3e-5,1.5e-4,1e-4,COL1A1/COL3A1/COL1A2,3
R-HSA-76009,Platelet Aggregation (Plug Formation),3/33,32/9133,2e-4,0.0012,8.5e-4,FN1/COL1A1/COL1A2,3
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,3/33,36/9133,2.8e-4,0.0016,0.0012,COL1A1/COL3A1/COL1A2,3
R-HSA-1566948,Elastic fibre formation,3/33,42/9133,4.5e-4,0.0025,0.0017,FN1/LOX/ITGA8,3
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,4/33,109/9133,6e-4,0.0032,0.0023,COL1A1/COL3A1/COL1A2/COL2A1,4
R-HSA-75892,Platelet Adhesion to exposed collagen,2/33,12/9133,8.2e-4,0.0041,0.0029,COL1A1/COL1A2,2
R-HSA-2022857,Keratan sulfate degradation,2/33,13/9133,9.6e-4,0.0047,0.0033,ACAN/OGN,2
R-HSA-2022854,Keratan sulfate biosynthesis,2/33,28/9133,0.0045,0.021,0.015,ACAN/OGN,2
R-HSA-114604,GPVI-mediated activation cascade,2/33,34/9133,0.0066,0.029,0.021,COL1A1/COL1A2,2
R-HSA-1638074,Keratan sulfate/keratin metabolism,2/33,34/9133,0.0066,0.029,0.021,ACAN/OGN,2
R-HSA-2129379,Molecules associated with elastic fibres,2/33,35/9133,0.007,0.03,0.021,FN1/ITGA8,2
R-HSA-202733,Cell surface interactions at the vascular wall,3/33,115/9133,0.0081,0.033,0.024,FN1/COL1A1/COL1A2,3
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,2/33,39/9133,0.0086,0.035,0.025,ACAN/OGN,2
R-HSA-76002,"Platelet activation, signaling and aggregation",4/33,232/9133,0.0093,0.036,0.026,FN1/COL1A1/COL1A2/TRPC3,4